Utilisation and Safety of Asenapine in Secondary Care in the UK: Results from the Observational Safety Evaluation of Asenapine (OBSERVA) Study

被引：0
|
作者：
Dhanda, S. [1 ,2 ]
Slade, J. [1 ]
Obsorne, V. [1 ]
Wise, L. [1 ]
Shakir, S. [1 ,2 ]
机构：
[1] Drug Safety Res Unit, Southampton, Hants, England
[2] Univ Portsmouth, Portsmouth, Hants, England
来源：
DRUG SAFETY | 2018年 / 41卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
ISoP18-106
引用
收藏
页码：1129 / 1130
页数：2
相关论文
共 50 条
  • [21] Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia
    Cazorla, Pilar
    Mackle, Mary
    Zhao, Jun
    Ha, Xianwei
    Szegedi, Armin
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 247 - 257
  • [22] Incidence of major and clinically relevant non-major (CRNM) bleeding in patients prescribed rivaroxaban in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study
    Evans, Alison
    Davies, Miranda
    Wise, Lesley
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 456 - 457
  • [23] Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study
    Durgam, Suresh
    Landbloom, Ronald P.
    Mackle, Mary
    Wu, Xiao
    Mathews, Maju
    Nasrallah, Henry A.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2021 - 2035
  • [24] Safety of pertussis vaccination in pregnant women in UK: observational study
    Donegan, Katherine
    King, Bridget
    Bryan, Phil
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [25] A PHASE I STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SINGLE AND MULTIPLE DOSES OF SUBLINGUALLY ADMINISTERED ASENAPINE IN HEALTHY MALE VOLUNTEERS
    Dogterom, P.
    Timmer, C.
    de Greef, R.
    Spaans, E.
    de Vries, D.
    Peeters, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S86 - S87
  • [26] Utilisation and Safety of Low Molecular Weight HeparinsProspective Observational Study in Medical Inpatients
    Philippe Cestac
    Haleh Bagheri
    Maryse Lapeyre-Mestre
    Pierre Sié
    Atoussa Fouladi
    Eric Maupas
    Philippe Léger
    Bernard Fontan
    Patrice Massip
    Jean-Louis Montastruc
    Drug Safety, 2003, 26 : 197 - 207
  • [27] Patient safety in intensive care: results from the multinational Sentinel Events Evaluation (SEE) study
    Valentin, Andreas
    Capuzzo, Maurizia
    Guidet, Bertrand
    Moreno, Rui P.
    Dolanski, Lorenz
    Bauer, Peter
    Metnitz, PhilippG. H.
    INTENSIVE CARE MEDICINE, 2006, 32 (10) : 1591 - 1598
  • [28] Efficacy and Safety of an Asenapine Transdermal Patch (Asenapine Transdermal System, HP-3070) in the Treatment of Adults With Schizophrenia: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 6-Week Inpatient Study
    Citrome, Leslie
    Walling, David
    Zeni, Courtney
    Komaroff, Marina
    Park, Alexandra
    BIOLOGICAL PSYCHIATRY, 2019, 85 (10) : S126 - S126
  • [29] Efficacy and Safety of an Asenapine Transdermal Patch (Asenapine Transdermal System, HP-3070) in the Treatment of Adults With Schizophrenia: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 6-Week, Inpatient Study
    Citrome, Leslie
    Walling, David
    Zeni, Courtney
    Komaroff, Marina
    Park, Alexandra
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S343 - S344
  • [30] Patient safety in intensive care: results from the multinational Sentinel Events Evaluation (SEE) study
    Andreas Valentin
    Maurizia Capuzzo
    Bertrand Guidet
    Rui P. Moreno
    Lorenz Dolanski
    Peter Bauer
    Philipp G. H. Metnitz
    Intensive Care Medicine, 2006, 32 : 1591 - 1598
12345